The effect of performance score, prognostic nutritional index, serum neutrophil-to-lymphocyte ratio, and thrombocyte-to-lymphocyte ratio on prognosis in non-small cell lung cancer

Basit Öğe Kaydı
dc.authoridYasemin Kemal / 0000-0002-1175-9085
dc.authorscopusidYasemin Kemal / 23479972900
dc.authorwosidYasemin Kemal / CYJ-7779-2022
dc.contributor.authorTuna, Tibel
dc.contributor.authorKemal, Yasemin
dc.contributor.authorGüllü, Yusuf Taha
dc.contributor.authorKöksal, Nurhan
dc.contributor.authorAla, Selen
dc.date.accessioned2022-04-06T05:45:31Z
dc.date.available2022-04-06T05:45:31Z
dc.date.issued2022en_US
dc.departmentİstinye Üniversitesien_US
dc.description.abstractObjective: Systemic inflammatory markers and nutritional status of the patients can be helpful both in identifying high-risk cancer patients and in showing the prognosis of the disease. In this study we aimed to determine the effects of nutritional status and systemic inflammatory markers on prognosis in non-small cell lung cancer. Patients and Methods: Patients diagnosed with non-small cell lung cancer between 2015 and 2019 were analyzed retrospectively. The prognostic nutritional index (PNI), platelet-to-lymphocyte ratio (PLR) and neutrophil-to-lymphocyte ratio(NLR) were calculated and Eastern Cooperative Oncology Group performance status (ECOG PS), and the dates of death or last follow-up were recorded. Cox regression analysis and Kaplan-Meier curves were used to analyze the effects of parameters on survival. Results: In the study, a total of 219 patients were analyzed. 85.4% of the patients had died. At the third step Cox regression model, ECOG 3-4 (HR:2.18), PLR (HR:1.20) and PNI (HR:1.12) predicted the survival times. Patients with PNI>45 had a higher median survival (495 days) than patients with PNI<45 (314 days). Conclusion: In order to determine the prognosis of the patients at the time of diagnosis, it is recommended to use PNI and PLR values, which can he obtained through repeated tests and evaluated at low cost, together with performance scores.en_US
dc.identifier.citationTuna, T., Kemal, Y., Gullu, Y. T., Koksal, N., Ala, S. (2022). The effect of performance score, prognostic nutritional index, serum neutrophil-to-lymphocyte ratio, and thrombocyte-to-lymphocyte ratio on prognosis in non-small cell lung cancer. Marmara Medical Journal, 35(1), 94-99.en_US
dc.identifier.doi10.5472/marumj.1065820en_US
dc.identifier.endpage99en_US
dc.identifier.issn1309-9469en_US
dc.identifier.issue1en_US
dc.identifier.scopus2-s2.0-85128450824en_US
dc.identifier.scopusqualityQ4en_US
dc.identifier.startpage94en_US
dc.identifier.urihttps://doi.org/10.5472/marumj.1065820
dc.identifier.urihttps://hdl.handle.net/20.500.12713/2612
dc.identifier.volume35en_US
dc.identifier.wosWOS:000765507600008en_US
dc.identifier.wosqualityN/Aen_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.institutionauthorKemal, Yasemin
dc.language.isoenen_US
dc.publisherMARMARA UNIVen_US
dc.relation.ispartofMARMARA MEDICAL JOURNALen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectLung Canceren_US
dc.subjectInflammationen_US
dc.subjectNutritional Statusen_US
dc.titleThe effect of performance score, prognostic nutritional index, serum neutrophil-to-lymphocyte ratio, and thrombocyte-to-lymphocyte ratio on prognosis in non-small cell lung canceren_US
dc.typeArticleen_US

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim
İsim:
Tuna-2022-The-effect-of-performance-score-pro.pdf
Boyut:
402.46 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin / Full Text
İndir
Lisans paketi
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
license.txt
Boyut:
1.44 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama:
İndir

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu